---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-001567"
form_type: "8-K"
ticker: "CLDI"
cik: "0001855485"
company_name: "Calidi Biotherapeutics, Inc."
filed_at: "2025-01-10T23:59:59+00:00"
generated_at: "2026-05-28T05:38:21.345610+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Calidi Biotherapeutics prices $4.25M public offering of 5M shares at $0.85/share

## Summary
- Priced public offering of 5,000,000 shares at $0.85 per share for gross proceeds of $4.25 million.
- Ladenburg Thalmann acting as exclusive placement agent; fees include 8% cash fee plus 1% management fee.
- Placement agent warrants issued to purchase 250,000 shares at $1.0625 per share (125% of offering price).
- Lock-up agreements: company 15 days, directors/officers 90 days from closing; agent may waive.
- Net proceeds to be used for working capital and general corporate purposes.

## SEC filing metadata
- accession: 0001493152-25-001567
- form_type: 8-K
- ticker: CLDI
- cik: 0001855485
- company_name: Calidi Biotherapeutics, Inc.
- filed_at: 2025-01-10T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 3.02, 7.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1855485/000149315225001567/0001493152-25-001567-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1855485/000149315225001567/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-001567
- JSON: https://secwatch.observer/filing/0001493152-25-001567.json
- Plain text: https://secwatch.observer/filing/0001493152-25-001567.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.